Fitness doesn’t make people immune to atherosclerosis, but what to do with the finding in asymptomatic patients is uncertain.

Surgery is the gold standard, GLP-1s are all the rage—whether a head-to-head study is needed depends on who you ask.

Vinod Thourani and Larry Epstein explore the current field of tricuspid intervention as well as challenges within lead ...

In the year before amputation, a deep divide was seen between patients who got specialist care and those who did not.

The ARIES-HM3 substudy may help persuade implanters who are less well-versed in the circulatory changes an LVAD affords.

Two new trials saw no impact of thrombolytics in reducing disability at 90 days, but some positive signals offer hope.

An app-based program failed to boost function for most at 3 months, but positive signs were seen in women and after CABG.

The agency says the strategy would help millions quit and prevent 4.3 million tobacco-related deaths by the end of the ...

The aim is to make it easier for consumers to determine how much saturated fat, sodium, and added sugar are inside.

The two-tiered classification focuses on preclinical and clinical stages of disease, and should help inform treatment ...

The message is that an early decrease in eGFR with finerenone should not lead to stopping the medication, say HF experts.

Greater transparency, monitoring, and regulatory oversight are needed around these transactions, a researcher says.